NCT00476463View on ClinicalTrials.gov

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Hepatitis B VirusHIV Infections

Interventions

DRUG

Emtricitabine

Emtricitabine 200 mg OD + Zidovudine 300 mg BID + EFV OD compared to TDF + FTC + EFV

Trial Locations (1)

10330

HIV-NAT Thai Red Cross AIDS Research Center, Bangkok

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

collaborator

Ministry of Health, Thailand

OTHER_GOV

lead

The HIV Netherlands Australia Thailand Research Collaboration

OTHER